Project: REspiratory microbiome and clinical Data AnaLysis for the prediction of acute exacERbaTions in COPD

Acronym REDALERT (Reference Number: 113530)
Duration 01/12/2019 - 03/12/2022
Project Topic REDALERT will develop the first-ever test to predict chronic obstructive pulmonary disease (COPD) exacerbations through analysis of the respiratory tract microbiome (RTM), integration with clinical parameters and stratification of COPD patients. The product will consist of an RTM analysis kit combined with a software platform for clinical decision making. It will allow routine sampling of microbiome data for COPD patients and enable better management through stratification.
Network Eurostars 2
Call Eurostars Cut–off 11

Project partner

Number Name Role Country
1 IS-diagnostics Ltd Coordinator Netherlands
2 GeneXplain GmbH Partner Germany
3 Maastricht University Medical Center Partner Netherlands
4 CIRO Partner Netherlands
5 Johann Wolfgang Goethe-Universität Frankfurt am Main Partner Germany